Home » Topics » Disease categories and therapies » Immune

Immune
RSS

MT-204: mAb with immunosuppressive and antiproliferative activity

Nov. 6, 2006

Recent patents cover novel immunomodulators

Oct. 24, 2006

Rigel selects R-348 for advanced preclinical development

Oct. 20, 2006

Positive preclinical results for PLX-I

Oct. 19, 2006

Tokyo University of Science patent discloses novel agents for preventing transplant rejection

Oct. 6, 2006

Fast track designations for talactoferrin alfa in NSCLC and diabetic foot ulcers

Oct. 6, 2006

Sanofi pasteur and PDVI partner on dengue vaccine initiatives

Oct. 5, 2006

Grazax approved in E.U.

Sep. 27, 2006

NDA submission for orBec in gastrointestinal GVHD

Sep. 27, 2006

Novel therapeutic agents for immune disorders, transplant rejection, etc.

Sep. 14, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...
Brain-penetrant NLRP3 inhibitor shows promise in Parkinson’s
BioWorld Science
Researchers from Changchun Genescience Pharmaceuticals Co. Ltd. described the discovery and preclinical profile of an NLRP3 inhibitor with favorable brain...
GSK’s newly acquired Jideytro wins FDA nod in NSCLC
BioWorld
About a week after closing its $10.6 billion acquisition of Nuvalent Inc., GSK plc has reaped the first reward, announcing U.S. FDA approval of zidesamtinib in...